Whalesbook
Toh hua yun ki Prabhudas Lilladher ne JLHL par analyst coverage start kiya hai aur seedha 'BUY' rating de di hai. Unka target price hai ₹1,600, matlab current prices se lagbhag 20-24% ka upside dekh rahe hain woh log. Ye rating unki strong Q4 results aur future expansion plans ko dekh kar di gayi hai.
Growth ka forecast kya hai?
Brokerage ka andaaza hai ki FY28 tak company ka EBITDA 17% ke CAGR (Compound Annual Growth Rate) se badhega. Agar FY26 se FY28 ki baat karein, toh PAT bhi 10% CAGR se grow kar sakta hai. Ye sab inke alag-alag hospitals mein occupancy rates badhne ki wajah se hoga.
Q4 mein performance kaisi rahi?
Company ne fourth quarter mein consolidated EBITDA 12% saal-dar-saal badhaya hai, jo ki ₹892 million raha. Agar Dombivli unit ke losses hata dein, toh adjusted EBITDA toh 24% bhaag gaya tha!
Hospitals ka network aur expansion plan
JLHL ke paas abhi Thane, Pune, Indore aur Dombivli mein 4 hospitals hain, jinmein total lagbhag 1,248 beds hain. Ye log West India mein naye greenfield projects par focus kar rahe hain, taaki future demand poori kar sakein aur apni market position bana sakein.
Valuation aur peers se comparison
Current valuation ki baat karein toh JLHL 42.90x se 48.50x ke P/E par trade kar raha hai. Yeh healthcare sector mein growth stocks ke liye normal hai. Bade players jaise Apollo Hospitals (P/E 62-71x) ya Max Healthcare Institute (P/E 68-100x) se thoda kam hai, par sector average (~41.9x-43.2x) se toh upar hi hai. Lekin company ka valuation is baat par depend karta hai ki woh kitna revenue grow karti hai aur margins maintain kar paati hai.
Sector mein kya chal raha hai?
Indian healthcare sector toh waise bhi mast chal raha hai. Log health par zyada kharch kar rahe hain, income badh rahi hai, population bhi badh rahi hai. Government bhi support kar rahi hai. Is wajah se Nifty Healthcare Index bhi stable raha hai aur companies achha revenue grow kar rahi hain.
Kya hain risks?
Par bhai, risk bhi hai. Dombivli unit mein jo losses ho rahe hain, unko manage karna hoga. Naye projects time par aur budget mein banayein, yeh bhi ek challenge hai. Aur bhai, 45x se upar ka P/E matlab expectations bahut high hain. Agar growth targets miss hue ya koi operational issue aaya, toh stock gir sakta hai. Competition bhi kaafi tight hai, jisse prices aur profit margins par pressure aa sakta hai.
Aage kya expect karein?
Analysts generally JLHL ke liye 'Strong Buy' ka consensus rakhte hain aur average price targets acche upside dikha rahe hain. Company ka expansion plan aur operational efficiency par focus continue karna chahiye. Investors ko dekhna hoga ki company naye facilities ko kaise manage karti hai, costs control karti hai aur occupancy rates maintain rakhti hai. Agar sab theek raha, toh shareholder value badhne ki ummeed hai.